Celastrol attenuates amphiregulin expression by inhibiting MAPK signaling pathway in triple-negative breast cancer cells

Background: Amphiregulin (AREG) plays an essential role in the metastasis and angiogenesis of various cancers. Purpose: The objective of this study was to investigate the pharmacological effects of celastrol on AREG expression in triple-negative breast cancer (TNBC) cells. Methods: We analyzed the p...

Full description

Bibliographic Details
Published in:	Phytomedicine Plus
Main Authors:	Sangmin Kim, Daeun You, Yisun Jeong, Sun Young Yoon, Eunji Lo, Jeong Eon Lee
Format:	Article
Language:	English
Published:	Elsevier 2022-08-01
Subjects:	Celastrol AREG EGFR MEK/ERK signaling pathway
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667031322001002

Similar Items

17β-Estradiol Promotes Tumorigenicity Through an Autocrine AREG/EGFR Loop in ER-α-Positive Breast Cancer Cells
by: Sun Young Yoon, et al.
Published: (2025-05-01)

Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction
by: Mian Cheng, et al.
Published: (2016-05-01)

A critical role of AREG for bleomycin-induced skin fibrosis
by: Mary Yinghua Zhang, et al.
Published: (2021-02-01)

CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma
by: Cynthia M Simbulan-Rosenthal, et al.
Published: (2024-05-01)

Stress‐induced Rab11a‐exosomes induce amphiregulin‐mediated cetuximab resistance in colorectal cancer
by: John D. Mason, et al.
Published: (2024-06-01)

Blood and Salivary Amphiregulin Levels as Biomarkers for Asthma
by: Mahmood Yaseen Hachim, et al.
Published: (2020-10-01)

Amphiregulin Regulates Melanocytic Senescence
by: Michaela Pommer, et al.
Published: (2021-02-01)

Biphasic regulation of osteoblast development via the ERK MAPK–mTOR pathway
by: Jung-Min Kim, et al.
Published: (2022-08-01)

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
by: Jimin Yuan, et al.
Published: (2020-08-01)

An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation
by: Jeffrey J. Heard, et al.
Published: (2018-01-01)

SHP2 inhibition improves celastrol-induced growth suppression of colorectal cancer
by: Linxi Zhang, et al.
Published: (2022-09-01)

Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
by: Zhang Xiangchao, et al.
Published: (2023-06-01)

Hepatic stellate cell-specific Kcnma1 deletion mitigates metabolic dysfunction-associated steatotic liver disease progression via upregulating Amphiregulin secretion
by: Yunhan Zou, et al.
Published: (2025-07-01)

Evaluation of Amphiregulin and Epiregulin mRNA Expressions as Prognostic Biomarkers for Patients With Stage III Colorectal Cancer
by: Takeshi Ishita, et al.
Published: (2022-03-01)

Mucosal-associated invariant T cells promote ductular reaction through amphiregulin in biliary atresiaResearch in context
by: Man-Huan Xiao, et al.
Published: (2024-05-01)

Liprin‐α1 contributes to oncogenic MAPK signaling by counteracting ERK activity
by: Henna Pehkonen, et al.
Published: (2024-03-01)

Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation
by: Jingwen Liu, et al.
Published: (2025-08-01)

Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
by: Liu Rui, et al.
Published: (2023-06-01)

Prognostic significance of EGFR, AREG and EREG amplification and gene expression in muscle invasive bladder cancer
by: Daniel Uysal, et al.
Published: (2024-05-01)

Celastrol alleviates arthritis by modulating the inflammatory activities of neutrophils
by: Kai Yuan, et al.
Published: (2017-01-01)

Cobimetinib and trametinib inhibit platelet MEK but do not cause platelet dysfunction
by: Amanda J. Unsworth, et al.
Published: (2019-08-01)

Degradation‐Based Protein Profiling: A Case Study of Celastrol
by: Zhihao Ni, et al.
Published: (2024-07-01)

Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF
by: Mingxia Song, et al.
Published: (2023-12-01)

Enhanced amphiregulin exposure promotes modulation of the high grade serous ovarian cancer tumor immune microenvironment
by: Jasmine Ebott, et al.
Published: (2024-05-01)

ELABELA targets the MEK/ERK axis to enhance trophoblast invasion in early-onset preeclampsia
by: Lijing Wang, et al.
Published: (2025-08-01)

Development of Dual-Targeted Mixed Micelles Loaded with Celastrol and Evaluation on Triple-Negative Breast Cancer Therapy
by: Siying Huang, et al.
Published: (2024-09-01)

Triiodothyronine (T3) increases the expression of the amphiregulin (AREG) oncogene by activating extranuclear pathways in MCF-7 breast cancer cells
by: Maria Teresa De Sibio, et al.
Published: (2025-01-01)

Celastrol Supplementation Ablates Sexual Dimorphism of Abdominal Aortic Aneurysm Formation in Mice
by: Aida Javidan, et al.
Published: (2023-03-01)

Celastrol and Rhynchophylline in the mitigation of simulated muscle atrophy under in vitro
by: Maksymilian Wastag, et al.
Published: (2022-10-01)

Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases
by: Rita Cascão, et al.
Published: (2017-06-01)

Chemoproteomics-based profiling reveals potential antimalarial mechanism of Celastrol by disrupting spermidine and protein synthesis
by: Peng Gao, et al.
Published: (2024-02-01)

Celastrol attenuates impairments associated with lipopolysaccharide-induced acute respiratory distress syndrome (ARDS) in rats
by: Yongjun Wei, et al.
Published: (2017-01-01)

Neuroprotective effects of celastrol on sciatic nerve transection model in male Wistar rats
by: Haider Faleh Al-Saedi, et al.
Published: (2022-10-01)

Celastrol: A Promising Agent Fighting against Cardiovascular Diseases
by: Zhexi Li, et al.
Published: (2022-08-01)

Formulation and Evaluation of Celastrol-Loaded Liposomes
by: Luyong Zhang, et al.
Published: (2011-09-01)

Celastrol attenuates sodium oxalate-induced acute kidney injury and crystal deposition by inhibiting NF-κB
by: LIU Yiheng, et al.
Published: (2025-04-01)

Celastrol inhibits prostaglandin E2-induced proliferation and osteogenic differentiation of fibroblasts isolated from ankylosing spondylitis hip tissues in vitro
by: Zou YC, et al.
Published: (2016-03-01)

Bacteria-Assisted Celastrol Liposomes for Effective Chemotherapy Against Lung Cancer in Mice Model
by: Wang X, et al.
Published: (2025-04-01)

Development and Evaluation of Liposomal <i>Celastrol</i>-PROTACs for Treating Triple-Negative Breast Cancer
by: Xuebin Li, et al.
Published: (2025-09-01)

Celastrol loaded nanocomplex for painless tumor therapy via YAP inhibition
by: Zhaokun Hao, et al.
Published: (2025-04-01)